Cryo-Cell International (CCEL) vs Joint (JYNT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Cryo-Cell International (CCEL) has outperformed Joint (JYNT) over the past year, losing 6.9% versus a loss of 18.9%. Over five years, CCEL leads with a -68.3% price change compared with -91.1% for JYNT. Joint is the larger company by market cap ($100.7 million vs $33.6 million), about 3.0 times the size.
On valuation, Joint trades at a lower forward P/E (10.7x vs 208.5x for Cryo-Cell International).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CCEL | JYNT |
|---|---|---|
| Share price | $4.17 | $7.12 |
| Market cap | $33.62M | $100.70M |
| 1-day change | +6.65% | -1.11% |
| YTD return | +21.22% | -18.35% |
| 1-year return | -6.92% | -18.91% |
| 5-year return | -68.29% | -91.06% |
| P/E ratio (TTM) | — | 50.86 |
| Forward P/E | 208.50 | 10.71 |
| EPS (TTM) | $-0.31 | $0.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.90 | $10.67 |
| 52-week low | $2.72 | $6.99 |
| Distance from 52-week high | -14.90% | -33.27% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +40.45% |
| Average volume | 24.02K | 78.48K |
| Shares outstanding | 8.06M | 14.14M |
| Employees | 72 | 202 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Care Facilities | Medical Care Facilities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Joint is about 3.0 times larger than Cryo-Cell International by market value ($100.70M vs $33.62M).
- CCEL has outperformed JYNT by 12.0 percentage points over the past year.
About Cryo-Cell International
CCEL stock →Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States.
Healthcare · Medical Care Facilities · 72 employees
About Joint
JYNT stock →The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States.
Healthcare · Medical Care Facilities · 202 employees
CCEL vs JYNT FAQ
Which is bigger, Cryo-Cell International or Joint?
Joint (JYNT) is larger, with a market capitalization of $100.70M compared with $33.62M for Cryo-Cell International (CCEL).
Which stock has performed better over the past year, CCEL or JYNT?
CCEL returned -6.92% over the past 12 months, compared with -18.91% for JYNT (price return, excluding dividends). Past performance does not predict future results.
Are Cryo-Cell International and Joint in the same industry?
Yes. Both are classified in the Medical Care Facilities industry within the Healthcare sector.